Feb 26, 2016Assessment of ANAVEX 2-73 in a MECP2 Rett Syndrome Mouse Model2016 Epilepsy Pipeline Conference, San Francisco, California Christopher U. Missling, PhD View Presentation
2016 Epilepsy Pipeline Conference, San Francisco, California Christopher U. Missling, PhD View Presentation
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal
